NEW YORK, Feb. 6 - Molecular pathology and proteomics company LifeSpan Biosciences has appointed Daniel Chen as vice president of marketing and business development. The announcement was made in a statement on Tuesday.
Chen will help the firm seek new partnerships and expand its business focus, according to company president and CEO Joseph Brown.
Chen was previously business director for anesthesia monitoring at Alaris Medical Systems, which manufactures medical devices. He also has been a management consultant in healthcare and pharmaceuticals for A.T. Kearney.
LifeSpan is a privately held company based in Seattle, Wash. It is working on a comprehensive atlas of human gene expression in normal and diseased tissue, and provides drug target validation services and gene localization databases to biotech and pharmaceutical companies.
Exelixis has appointed Robert Myers as executive vice president, the company said on Monday. Myers' duties will include building the company's pharmaceutical business and expanding commercial development and business alliances. He will report to George Scangos, the company's CEO and president.
Myers was most recently senior vice president of commercial development at ALZA Corporation, a pharmaceutical company that recently merged with Johnson & Johnson. At that company, he oversaw strategic planning, new products, mergers and acquisitions and licensing.
South San Francisco, Calif.-based Exelixis is a genomics-based research and development firm focused on drug discovery. It has partnerships with a range of pharmaceutical and agricultural biotechnology companies.
In May, computer scientist Peter Freeman will take on a new role at the National Science Foundation as assistant director for Computer and Information Science and Engineering.
The Directorate for Computer and Information Science and Engineering is a multidisciplinary directorate of NSF that supports computer, communications, and information researchers and encourages collaboration between computer scientists and engineers, mathematicians, biological and social scientists. It has a budget of roughly $400 million.
The assistant director helps to establish and manage all policies and programs and supervises the NSF-wide Information Technology Research Initiative.
Freeman is currently dean of computing at Georgia Institute of Technology, and is a founding dean of the institute's College of Computing. He was also the university's chief information officer.
Freeman replaces University of Pennsylvania computer scientist Ruzena Bajcsy, who held the position since December 1998.
Philadelphia-based Morphotek said on Feb. 1 that it had appointed William Heilman as the company's new vice president of business development.
Heilman will help guide the company's expansion plans. He will also develop new partnerships and negotiate licensing agreements
Heilman comes from American Home Products, where he evaluated and licensed new technology, and was involved in early stage pharmaceutical and agrochemical product development.
Morphotek, a privately owned company, works to develop new variants of cells, animals and plants with commercially useful agricultural and pharmaceutical applications like antibody or protein production.
Zymark Corporation has added a new executive vice president and internally promoted two vice presidents, the company said in a statement on Jan. 30.
Mark Roskey will be the company's new executive vice president for worldwide marketing. He was previously director of marketing at Applied Biosystems.
Auro Nair, who has been in sales with the company for four years, will now be vice president of North American sales.
Jean-Louis Rufener, who has worked for two and a half years with the company, will be vice president of international operations. He was previously president of SCITEC Automation Holdings, a Swiss lab automation company that Zymark purchased in 1999.
Zymark, based in Hopkinton, Mass., produces lab machines that use automated and robotic technology.